Capital Fund Management (CFM)
MYOK

Capital Fund Management (CFM)’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Capital Fund Management (CFM)’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-10,900
Closed -$547K – 1990
2019
Q2 		$547K Buy
10,900
+5,700
+110% +$277K 0.01% 1186
2019
Q1 		$270K Buy
+5,200
New +$240K ﹤0.01% 1481

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Bellevue Group
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Capital Fund Management (CFM)'s MYOK Position: Q3 2019 in Review

Capital Fund Management (CFM) sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2019, closing a stake of 10,900 shares — an estimated $547K sold.

Capital Fund Management (CFM) first reported a position in MYOK in Q1 2019 and held it in 2 quarters. The position peaked at $547K in Q2 2019. 157 funds tracked by Wall St. Rank hold MYOK as of Q3 2019.

  • Capital Fund Management (CFM) reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 10,900 MyoKardia, Inc. Common Stock shares in Q3 2019, an estimated $547K.
  • Capital Fund Management (CFM) first reported a position in MyoKardia, Inc. Common Stock in Q1 2019 and held it in 2 quarters.
  • Capital Fund Management (CFM)'s MyoKardia, Inc. Common Stock position peaked at $547K in Q2 2019.
  • 157 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2019.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2019, filed 13 Nov 2019.